ZA200006523B - BASB029 polynucleotide(s) and polypeptides from neisseria meningitidis. - Google Patents

BASB029 polynucleotide(s) and polypeptides from neisseria meningitidis.

Info

Publication number
ZA200006523B
ZA200006523B ZA200006523A ZA200006523A ZA200006523B ZA 200006523 B ZA200006523 B ZA 200006523B ZA 200006523 A ZA200006523 A ZA 200006523A ZA 200006523 A ZA200006523 A ZA 200006523A ZA 200006523 B ZA200006523 B ZA 200006523B
Authority
ZA
South Africa
Prior art keywords
polypeptides
neisseria meningitidis
basb029
basb029 polynucleotide
polynucleotide
Prior art date
Application number
ZA200006523A
Other languages
English (en)
Inventor
Jean-Louis Ruelle
Original Assignee
Smithkline Beecham Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10831992&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200006523(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog
Publication of ZA200006523B publication Critical patent/ZA200006523B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1217—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Plant Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
ZA200006523A 1998-05-13 2000-11-10 BASB029 polynucleotide(s) and polypeptides from neisseria meningitidis. ZA200006523B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9810276.7A GB9810276D0 (en) 1998-05-13 1998-05-13 Novel compounds

Publications (1)

Publication Number Publication Date
ZA200006523B true ZA200006523B (en) 2001-11-12

Family

ID=10831992

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200006523A ZA200006523B (en) 1998-05-13 2000-11-10 BASB029 polynucleotide(s) and polypeptides from neisseria meningitidis.

Country Status (24)

Country Link
US (3) US6780419B1 (xx)
EP (2) EP1621623A3 (xx)
JP (2) JP4707832B2 (xx)
KR (4) KR20080070073A (xx)
CN (1) CN1322127C (xx)
AT (1) ATE311457T1 (xx)
AU (1) AU750032B2 (xx)
BR (1) BR9910396A (xx)
CA (1) CA2328403C (xx)
CY (1) CY1105676T1 (xx)
CZ (1) CZ299612B6 (xx)
DE (1) DE69928658T2 (xx)
DK (1) DK1078063T3 (xx)
ES (1) ES2252946T3 (xx)
GB (1) GB9810276D0 (xx)
HK (1) HK1036300A1 (xx)
HU (1) HUP0102479A3 (xx)
IL (2) IL139613A0 (xx)
NO (2) NO326994B1 (xx)
NZ (1) NZ508323A (xx)
PL (1) PL197449B1 (xx)
TR (1) TR200003347T2 (xx)
WO (1) WO1999058683A2 (xx)
ZA (1) ZA200006523B (xx)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9726398D0 (en) * 1997-12-12 1998-02-11 Isis Innovation Polypeptide and coding sequences
ES2333071T5 (es) * 1998-01-14 2015-08-17 Novartis Vaccines And Diagnostics S.R.L. Antígenos de Neisseria meningitidis
GB9810276D0 (en) * 1998-05-13 1998-07-15 Smithkline Beecham Biolog Novel compounds
JP4812942B2 (ja) 1999-02-26 2011-11-09 ノバルティス ヴァクシンズ アンド ダイアグノスティクス エスアールエル ＣＧモチーフを含むオリゴヌクレオチドを用いるＮｅｉｓｓｅｒｉａ抗原殺菌活性の増強
GB9916529D0 (en) * 1999-07-14 1999-09-15 Chiron Spa Antigenic peptides
EP2275551B1 (en) 1999-10-29 2015-04-08 Novartis Vaccines and Diagnostics S.r.l. Neisserial antigenic peptides
GB9928196D0 (en) 1999-11-29 2000-01-26 Chiron Spa Combinations of B, C and other antigens
BR0107679A (pt) * 2000-01-17 2004-07-06 Chiron Spa Vacina de vesìcula de membrana externa (omv) compreendendo proteìnas de membrana externa do grupo sérico b de neisseria meningitidis
AU2818101A (en) * 2000-01-25 2001-08-07 University Of Queensland, The proteins comprising conserved regions of neisseria meningitidis surface antigen NhhA
EP1790660B1 (en) 2000-02-28 2012-06-20 Novartis Vaccines and Diagnostics S.r.l. Heterologous expression of neisserial proteins
DK2248822T3 (en) 2001-07-27 2017-02-13 Glaxosmithkline Biologicals Sa MENINGOCOKKER ADHESIONS
JP4740738B2 (ja) 2002-08-02 2011-08-03 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム ワクチン
CN1809380B (zh) 2002-10-11 2010-05-12 启龙有限公司 广泛防御高毒性脑膜炎球菌谱系的多肽-疫苗
RU2378010C2 (ru) 2003-10-02 2010-01-10 Новартис Вэксинес Энд Дайэгностикс С.Р.Л. Жидкие вакцины для множественных серогрупп менингококков
US7459930B2 (en) * 2006-11-14 2008-12-02 Micron Technology, Inc. Digital calibration circuits, devices and systems including same, and methods of operation
GB0700562D0 (en) 2007-01-11 2007-02-21 Novartis Vaccines & Diagnostic Modified Saccharides
GB0916570D0 (en) 2009-09-21 2009-10-28 Royal Holloway & Bedford New C Method
WO2011110655A2 (en) 2010-03-11 2011-09-15 Glaxosmithkline Biologicals S.A. Vaccine
EA201491324A1 (ru) * 2012-01-05 2015-03-31 Дойчес Кребсфоршунгсцентрум Средства и методы лечения или диагностики раковых заболеваний с мутацией r132h в гене idh1
CA3030387C (en) 2016-07-27 2023-10-31 Prysmian S.P.A. Flexible optical-fiber ribbon

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4769240A (en) * 1980-09-15 1988-09-06 Bactex, Inc. Pili of neisseria and vaccine compositions containing same
US4702911A (en) * 1985-09-27 1987-10-27 Immunomed Corporation Preparation of bacterium pili subunits and vaccines containing pili subunits
JPH01125328A (ja) 1987-07-30 1989-05-17 Centro Natl De Biopreparados 髄膜炎菌ワクチン
FR2682041B1 (fr) * 1991-10-03 1994-01-14 Pasteur Merieux Serums Vaccins Vaccin contre les infections a neisseria meningitidis.
US6245337B1 (en) * 1994-08-25 2001-06-12 Washington University Haemophilus adherence and penetration proteins
US6121037A (en) * 1994-10-18 2000-09-19 Stojiljkovic; Igor Bacterial hemoglobin receptor genes
US5646259A (en) * 1995-03-24 1997-07-08 St. Louis University DNA encoding haemophilus adhesion proteins
US6265567B1 (en) * 1995-04-07 2001-07-24 University Of North Carolina At Chapel Hill Isolated FrpB nucleic acid molecule
CU22559A1 (es) * 1996-01-17 1999-05-03 Ct Ingenieria Genetica Biotech Sistema de expresión de antígenos heterologos en e. coli como proteínas de fusión
GB9726398D0 (en) * 1997-12-12 1998-02-11 Isis Innovation Polypeptide and coding sequences
ES2333071T5 (es) * 1998-01-14 2015-08-17 Novartis Vaccines And Diagnostics S.R.L. Antígenos de Neisseria meningitidis
GB9810276D0 (en) * 1998-05-13 1998-07-15 Smithkline Beecham Biolog Novel compounds
ES2397918T3 (es) * 1999-04-30 2013-03-12 Novartis Vaccines And Diagnostics S.R.L. Antígenos Neisseriales conservados

Also Published As

Publication number Publication date
GB9810276D0 (en) 1998-07-15
WO1999058683A9 (en) 2002-05-02
DE69928658D1 (de) 2006-01-05
EP1078063B1 (en) 2005-11-30
WO1999058683A3 (en) 2000-04-06
HK1036300A1 (en) 2001-12-28
NO20005696D0 (no) 2000-11-10
PL345281A1 (en) 2001-12-03
KR100897951B1 (ko) 2009-05-18
CA2328403C (en) 2013-11-05
DK1078063T3 (da) 2006-04-03
NZ508323A (en) 2002-10-25
NO20005696L (no) 2001-01-11
EP1621623A2 (en) 2006-02-01
TR200003347T2 (tr) 2001-06-21
HUP0102479A2 (hu) 2001-10-28
KR20060076789A (ko) 2006-07-04
HUP0102479A3 (en) 2004-10-28
CZ299612B6 (cs) 2008-09-17
KR20100019461A (ko) 2010-02-18
CY1105676T1 (el) 2010-12-22
CZ20004202A3 (en) 2001-05-16
PL197449B1 (pl) 2008-03-31
WO1999058683A2 (en) 1999-11-18
BR9910396A (pt) 2001-10-30
KR20080070073A (ko) 2008-07-29
EP1621623A3 (en) 2009-02-18
IL139613A0 (en) 2002-02-10
AU750032B2 (en) 2002-07-11
NO326994B1 (no) 2009-03-30
US6780419B1 (en) 2004-08-24
EP1078063A2 (en) 2001-02-28
KR100673674B1 (ko) 2007-01-23
AU4142099A (en) 1999-11-29
US20040265332A1 (en) 2004-12-30
DE69928658T2 (de) 2006-06-14
JP2010166921A (ja) 2010-08-05
JP4707832B2 (ja) 2011-06-22
KR20010043571A (ko) 2001-05-25
CN1309707A (zh) 2001-08-22
ATE311457T1 (de) 2005-12-15
JP2002514424A (ja) 2002-05-21
CN1322127C (zh) 2007-06-20
CA2328403A1 (en) 1999-11-18
IL139613A (en) 2014-03-31
ES2252946T3 (es) 2006-05-16
US20090093622A1 (en) 2009-04-09
NO20090955L (no) 2001-01-11

Similar Documents

Publication Publication Date Title
ZA200006523B (en) BASB029 polynucleotide(s) and polypeptides from neisseria meningitidis.
WO1999055873A3 (en) Basb006 polynucleotide(s) and polypeptides from neisseria meningitis
PL345793A1 (en) Neisseria meningitidis
HK1038041A1 (en) Polynucleotides and polypeptides basb033 from neisseria meningitidis and their uses.
AU3164600A (en) Novel compounds
GB9809683D0 (en) Novel compounds
WO2000043519A3 (en) Neisseria meningitidis polypeptides
GB9812163D0 (en) Novel compounds
GB9810285D0 (en) Novel compounds
GB0025171D0 (en) Novel compounds
GB9812440D0 (en) Novel compounds
WO2000034482A3 (en) Novel compounds derived from neisseria meningitidis
GB9918208D0 (en) Novel compounds
GB0025170D0 (en) Novel compounds
GB9918302D0 (en) Novel compounds
GB9918003D0 (en) Novel compounds
GB9918206D0 (en) Novel compounds
GB0025169D0 (en) Novel compounds
HK1045331A1 (en) Basb111 polypeptide and polynucleotide from moraxella catharrhalis
GB9918281D0 (en) Novel compounds